Cargando…

Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix‐mediated tumor cell adaptation and tolerance to BRAF‐targeted therapy in melanoma

Resistance to BRAF/MEK inhibitor therapy in BRAF(V600)‐mutated advanced melanoma remains a major obstacle that limits patient benefit. Microenvironment components including the extracellular matrix (ECM) can support tumor cell adaptation and tolerance to targeted therapy; however, the underlying mec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berestjuk, Ilona, Lecacheur, Margaux, Carminati, Alexandrine, Diazzi, Serena, Rovera, Christopher, Prod’homme, Virginie, Ohanna, Mickael, Popovic, Ana, Mallavialle, Aude, Larbret, Frédéric, Pisano, Sabrina, Audebert, Stéphane, Passeron, Thierry, Gaggioli, Cédric, Girard, Christophe A, Deckert, Marcel, Tartare‐Deckert, Sophie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819497/ https://www.ncbi.nlm.nih.gov/pubmed/34957688 http://dx.doi.org/10.15252/emmm.201911814

Ejemplares similares

Blockade of the pro‐fibrotic reaction mediated by the miR‐143/‐145 cluster enhances the responses to targeted therapy in melanoma
por: Diazzi, Serena, et al.
Publicado: (2022)

Inhibitors of Discoidin Domain Receptor (DDR) Kinases for Cancer and Inflammation
por: Denny, William A., et al.
Publicado: (2021)

Bad Neighborhood: Fibrotic Stroma as a New Player in Melanoma Resistance to Targeted Therapies
por: Diazzi, Serena, et al.
Publicado: (2020)

Discoidin Domain Receptors, DDR1b and DDR2, Promote Tumour Growth within Collagen but DDR1b Suppresses Experimental Lung Metastasis in HT1080 Xenografts
por: Wasinski, Benjamin, et al.
Publicado: (2020)

Exploring the Cellular and Molecular Mechanism of Discoidin Domain Receptors (DDR1 and DDR2) in Bone Formation, Regeneration, and Its Associated Disease Conditions
por: Mariadoss, Arokia Vijaya Anand, et al.
Publicado: (2023)

The tyrosine kinase inhibitor nilotinib targets the discoidin domain receptor DDR2 in calcific aortic valve stenosis
por: Carracedo, Miguel, et al.
Publicado: (2022)

Discoidin Domain Receptor-1 (DDR1) is Involved in Angiolymphatic Invasion in Oral Cancer
por: Chen, Yu-Lian, et al.
Publicado: (2020)

Periostin interaction with discoidin domain receptor-1 (DDR1) promotes cartilage degeneration
por: Han, Tianzhen, et al.
Publicado: (2020)

The mechanical phenotypic plasticity of melanoma cell: an emerging driver of therapy cross-resistance
por: Diazzi, Serena, et al.
Publicado: (2023)

Glycosylation at Asn(211) Regulates the Activation State of the Discoidin Domain Receptor 1 (DDR1)
por: Fu, Hsueh-Liang, et al.
Publicado: (2014)

Expression and subcellular localization of Discoidin Domain Receptor 1 (DDR1) define prostate cancer aggressiveness
por: Bonfil, R. Daniel, et al.
Publicado: (2021)

Structure-Based Design of Tetrahydroisoquinoline-7-carboxamides as Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors
por: Wang, Zhen, et al.
Publicado: (2016)

TWIST1 induces expression of Discoidin Domain Receptor2 (DDR2) to Promote Ovarian Cancer Metastasis
por: Grither, Whitney R., et al.
Publicado: (2018)

Effects on Melanoma Cell Lines Suggest No Significant Risk of Melanoma Under Cladribine Treatment
por: Lebrun-Frenay, Christine, et al.
Publicado: (2020)

Evaluation of discoidin domain receptor-2 (DDR2) expression level in normal, benign, and malignant human prostate tissues
por: Azemikhah, Mitra, et al.
Publicado: (2015)

Silencing of Discoidin Domain Receptor-1 (DDR1) Concurrently Inhibits Multiple Steps of Metastasis Cascade in Gastric Cancer()
por: Yuge, Ryo, et al.
Publicado: (2018)

Spatial localisation of Discoidin Domain Receptor 2 (DDR2) signalling is dependent on its collagen binding and kinase activity
por: Luczynski, Maciej T., et al.
Publicado: (2018)

BMI1, ATM and DDR
por: Lin, Xiaozeng, et al.
Publicado: (2015)

Characterization of DDR2 Inhibitors for the Treatment of DDR2 Mutated Nonsmall Cell Lung Cancer
por: Terai, Hideki, et al.
Publicado: (2015)

The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer
por: Elkamhawy, Ahmed, et al.
Publicado: (2021)

Identification of Receptor Tyrosine Kinase, Discoidin Domain Receptor 1 (DDR1), as a Potential Biomarker for Serous Ovarian Cancer
por: Quan, Jinhua, et al.
Publicado: (2011)

ADAM10 controls collagen signaling and cell migration on collagen by shedding the ectodomain of discoidin domain receptor 1 (DDR1)
por: Shitomi, Yasuyuki, et al.
Publicado: (2015)

The C. elegans Discoidin Domain Receptor DDR-2 Modulates the Met-like RTK–JNK Signaling Pathway in Axon Regeneration
por: Hisamoto, Naoki, et al.
Publicado: (2016)

Deubiquitinase Inhibitors Impair Leukemic Cell Migration Through Cofilin Oxidation and Alteration of Actin Reorganization
por: Larbret, Frédéric, et al.
Publicado: (2022)

Identification of novel driver mutations of the discoidin domain receptor 2 (DDR2) gene in squamous cell lung cancer of Chinese patients
por: Miao, Liyun, et al.
Publicado: (2014)

Abnormal Accumulation of Collagen Type I Due to the Loss of Discoidin Domain Receptor 2 (Ddr2) Promotes Testicular Interstitial Dysfunction
por: Zhu, Chu-chao, et al.
Publicado: (2015)

Discoidin domain receptor 1 (DDR1) ablation promotes tissue fibrosis and hypoxia to induce aggressive basal-like breast cancers
por: Takai, Ken, et al.
Publicado: (2018)

Prevalence of Mutations in Discoidin Domain-Containing Receptor Tyrosine Kinase 2 (DDR2) in Squamous Cell Lung Cancers in Korean Patients
por: Lee, Mi-Sook, et al.
Publicado: (2017)

Discoidin Domain Receptor Tyrosine Kinase 1 (DDR1): A Novel Predictor for Recurrence of Hepatocellular Carcinoma After Curative Resection
por: Xu, Meng, et al.
Publicado: (2021)

Cell-ECM interactions control DDR
por: Dickreuter, Ellen, et al.
Publicado: (2015)

Collagen binding specificity of the discoidin domain receptors: Binding sites on collagens II and III and molecular determinants for collagen IV recognition by DDR1
por: Xu, Huifang, et al.
Publicado: (2011)

Inhibition of discoidin domain receptor (DDR)-1 with nilotinib alters CSF miRNAs and is associated with reduced inflammation and vascular fibrosis in Alzheimer’s disease
por: Stevenson, Max, et al.
Publicado: (2023)

DdrA, DdrD, and PprA: Components of UV and Mitomycin C Resistance in Deinococcus radiodurans R1
por: Selvam, Kathiresan, et al.
Publicado: (2013)

Targeting DDR2 enhances tumor response to anti–PD-1 immunotherapy
por: Tu, Megan M., et al.
Publicado: (2019)

DDR1 key for cancer cell escape
por: Leslie, Mitch
Publicado: (2014)

Inside the hypoxic tumour: reprogramming of the DDR and radioresistance
por: Begg, Katheryn, et al.
Publicado: (2020)

DNA Damage Response (DDR) and DNA Repair
por: Vernì, Fiammetta
Publicado: (2022)

The Epithelial-Mesenchymal Transition (EMT) Regulatory Factor SLUG (SNAI2) Is a Downstream Target of SPARC and AKT in Promoting Melanoma Cell Invasion
por: Fenouille, Nina, et al.
Publicado: (2012)

Why Human Papillomaviruses Activate the DNA Damage Response (DDR) and How Cellular and Viral Replication Persists in the Presence of DDR Signaling
por: Bristol, Molly L., et al.
Publicado: (2017)

DDR1 promotes LoVo cell proliferation by regulatingenergy metabolism: Effect of DDR1 on CRC cell metabolic reprogramming
por: Xiong, Bin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p9sc6gj11bn9mmd1sktgu5ai92